Cargando…

Prognostic role of neoplastic markers in Takotsubo syndrome

Takotsubo syndrome (TTS) is an acute heart failure syndrome with significant rates of in and out-of-hospital mayor cardiac adverse events (MACE). To evaluate the possible role of neoplastic biomarkers [CA-15.3, CA-19.9 and Carcinoembryonic Antigen (CEA)] as prognostic marker at short- and long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Francesco, Zimotti, Tecla, Mallardi, Adriana, Leopizzi, Alessandra, Vitale, Enrica, Tarantino, Nicola, Ferraretti, Armando, Solimando, Antonio Giovanni, Racanelli, Vito, Iacoviello, Massimo, Cannone, Michele, Di Biase, Matteo, Brunetti, Natale Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368165/ https://www.ncbi.nlm.nih.gov/pubmed/34400692 http://dx.doi.org/10.1038/s41598-021-95990-9

Ejemplares similares

Neutrophil/lymphocyte ratio predicts in‐hospital complications in Takotsubo syndrome. Results from a prospective multi‐center registry
por: Santoro, Francesco, et al.
Publicado: (2020)

Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis
por: Santoro, Francesco, et al.
Publicado: (2021)

Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
por: Correale, Michele, et al.
Publicado: (2021)

Impact of intra-aortic balloon counterpulsation on all-cause mortality among patients with Takotsubo syndrome complicated by cardiogenic shock: results from the German-Italian-Spanish (GEIST) registry
por: Santoro, Francesco, et al.
Publicado: (2023)

Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021)

Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
por: Santoro, Francesco, et al.
Publicado: (2018)

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
por: Correale, Michele, et al.
Publicado: (2018)

2019 Italian Society of Cardiology Census on telemedicine in cardiovascular disease: a report from the working group on telecardiology and informatics
por: Brunetti, Natale Daniele, et al.
Publicado: (2020)

Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
por: Correale, Michele, et al.
Publicado: (2021)

Takotsubo syndrome and cardiogenic shock: Authors' response
por: Santoro, Francesco, et al.
Publicado: (2023)

Left Ventricular Thrombi in Takotsubo Syndrome: Incidence, Predictors, and Management: Results From the GEIST (German Italian Stress Cardiomyopathy) Registry
por: Santoro, Francesco, et al.
Publicado: (2017)

Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death
por: Corbo, Maria Delia, et al.
Publicado: (2022)

Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
por: Brunetti, Natale Daniele, et al.
Publicado: (2020)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2019)

Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1—Pathophysiology and Diagnosis
por: Rawish, Elias, et al.
Publicado: (2021)

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
por: Santoro, Francesco, et al.
Publicado: (2023)

Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization
por: Correale, Michele, et al.
Publicado: (2020)

Near zero vascular complications using echo‐guided puncture during catheter ablation of arrhythmias: A retrospective study and literature review
por: Pellegrino, Pier Luigi, et al.
Publicado: (2022)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022)

SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
por: Correale, Michele, et al.
Publicado: (2023)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
por: Tarantino, Nicola, et al.
Publicado: (2017)

Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects
por: Susca, Nicola, et al.
Publicado: (2023)

Smoking influence in Takotsubo syndrome: insights from an international cohort
por: Núñez-Gil, Iván J., et al.
Publicado: (2023)

Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicenter GEIST registry
por: Arcari, Luca, et al.
Publicado: (2020)

Renal resistance index independently predicts worsening of renal function after coronary angiography
por: Barone, Roberta, et al.
Publicado: (2022)

Coronary thrombosis due to heparin‐induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent
por: Mele, Marco, et al.
Publicado: (2020)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
por: Argentiero, Antonella, et al.
Publicado: (2020)

Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
por: Tabella, Erika, et al.
Publicado: (2023)

Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction
por: Alcidi, Gianmarco, et al.
Publicado: (2023)

The PONTE (PDTA FOR INTEGRATED FOLLOW-UP TERRITORY HOSPITAL OF THE PATIENT WITH CARDIAC HEART FAILURE) (BRIDGE) Heart Failure project: increased adherence to guideline-recommended therapies through web-based shared clinical database
por: De Gennaro, Luisa, et al.
Publicado: (2022)

Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach
por: Monitillo, Francesco, et al.
Publicado: (2020)

Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
por: Correale, Michele, et al.
Publicado: (2021)

High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
por: Solimando, Antonio Giovanni, et al.
Publicado: (2019)

Don’t stop at first glance: pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jjlafijds80kh8j3at3ils62vm